Contact us for a demo Follow us:
Ypso-Facto sign two new strategic agreements in China
12 October 2025
We are delighted to announce that Ypso-Facto is expanding its footprint in Asia with the signing of two new strategic agreements in China. These partnerships mark an important step in accelerating the adoption of our Digital Twin solutions and supporting Industrial biotech with innovative,...
New leadership, shared ambition
Nearly six years ago, we joined the Ypso-Facto journey, eager to contribute and learn from a company driven by science and innovation. What we found exceeded our expectations: a unique environment, remarkable people, and exciting challenges at the crossroads of chemistry, biology, and process...Time flies like an arrow…
40 years have gone by since I graduated, 30 years since I created Novasep and 10 years since I created Ypso-Facto. At Ypso-Facto, during the last years we built simulation-based software taking the difficult path of mechanistic modeling. No matter the challenges, we have stayed true to our...
Bioprocess Development Symposium Celebrating Ypso-Facto’s 10th Anniversary
2-3 October 2024, Nancy
On October 2-3 2024, Ypso-Facto marked a significant milestone by hosting the Bioprocess Development Symposium in celebration of its 10th anniversary. This two-day event, held in Nancy, France, brought together industry leaders and innovators to explore the cutting edge of bioprocessing. The...
Ypso-Facto are pleased to announce that they got granted three families of patents
Ypso-Facto are pleased to announce that they got granted three families of patents in the last months: Method and device for simulating an industrial facility for exploiting a chemical or biochemical method EP 3 566 769 B1 System and method for simulating chemical or biochemical process EP...Ypso-Facto cooperates with SmarSEP Industries to provide process modeling and numerical simulation services for the Chinese Industrial Biotechnology Market.
Ypso-Facto® (Nancy, France), a leading provider of (bio)chemical process simulation software and services, has announced a cooperation agreement with Shanghai- based SmarSEP Industries to provide process modeling and numerical simulation services for the Chinese Industrial Biotechnology...
Ypso-Facto officially joins the ACCESS project
Ypso-Facto is proud to join officially the ACCESS project (Advanced Cell Control by Spectroscopic Sensors), a French R&D project aiming at improving the production of Advanced Therapy Medicinal products. This project is led by INDATECH – Chauvin Arnoux group, gathers MTInov, StemInov, Ondalys,...
PRESS RELEASE : Ypso-Facto is part of the CALIPSO project led by Sanofi, to disrupt the production of biomedicines!
Supported by Bpifrance, the CALIPSO project aims at developing a new generation of tools that will disrupt industrial bioproduction processes.
Nancy, France, 16 Sept 2021 - Ypso-Facto is proud to play a major role in this challenging and exciting project. With its expertise in bioprocesses and predictive simulation, Ypso-Facto will develop software solutions to support production of innovative therapies. The company will work on three...
Ypso-Facto is a service company helping industrial firms to develop, optimize and secure their chemical processes and bioprocesses.
© Ypso-Facto 2014 - Powered by Ealys | Legal Information